A Study of JNJ-40411813 as Supplementary Treatment to an Antidepressant in Adults With Depression and Anxiety Symptoms

Mise à jour : Il y a 5 ans
Référence : NCT01582815

Femme et Homme

Extrait

The purpose of this study is to evaluate the efficacy and overall safety and tolerability of treatment with adjunctive JNJ-40411813 compared to placebo in patients with MDD with anxiety symptoms being treated with an antidepressant.


Critère d'inclusion

  • Major Depressive Disorder


Liens